Fidelity Investments
TBIO

Fidelity Investments’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Fidelity Investments’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-13
Closed – – 5502
2022
Q2 		$0 Sell
13
-175
-93% -$12.1K ﹤0.01% 5601
2022
Q1 		$18K Buy
+188
New +$28.5K ﹤0.01% 4059

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity Investments's TBIO Position: Q3 2022 in Review

Fidelity Investments sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q3 2022, closing a stake of 13 shares.

Fidelity Investments first reported a position in TBIO in Q1 2022 and held it in 2 quarters. The position peaked at $18K in Q1 2022. 32 funds tracked by Wall St. Rank hold TBIO as of Q3 2022.

  • Fidelity Investments reported no remaining Telesis Bio, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Fidelity Investments sold 13 Telesis Bio, Inc. Common Stock shares in Q3 2022.
  • Fidelity Investments first reported a position in Telesis Bio, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Fidelity Investments's Telesis Bio, Inc. Common Stock position peaked at $18K in Q1 2022.
  • 32 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q3 2022.

Based on Fidelity Investments's 13F filing for Q3 2022, filed 10 Nov 2022.